Here we screened a cohort of unexplained Lynch-like families for the presence of EPCAM 4 deletions. We identified 27 novel independent MSH2-deficient families from multiple 5 geographical origins with varying deletions all encompassing the 3' end of EPCAM, but 6 leaving the MSH2 gene intact. Within the Netherlands and Germany, EPCAM deletions 7 appeared to represent at least 2.8% and 1.1% of the confirmed Lynch syndrome families, 8 respectively. MSH2 promoter methylation was observed in epithelial tissues of all deletion 9 carriers tested, thus confirming silencing of MSH2 as the causative defect. In a total of 45 10 families, 19 different deletions were found, all including the last two exons and the 11 transcription termination signal of EPCAM. All deletions appeared to originate from Alu-12 repeat mediated recombination events. In 17 cases regions of microhomology around the 13 breakpoints were found, suggesting non-allelic homologous recombination as the most likely 14 mechanism. We conclude that 3' end EPCAM deletions are a recurrent cause of Lynch 15 syndrome which should be implemented in routine Lynch syndrome diagnostics. 16 Page 4 of 30 John Wiley & Sons, Inc. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The most frequently diagnosed colorectal cancer (CRC) syndrome is Lynch syndrome, also 2 known as hereditary non-polyposis colorectal cancer (HNPCC) (MIMs 120435, 609310) , 3 which accounts for up to 5% of CRCs. Mutation carriers exhibit a high risk to develop CRC 4 (60-90%), endometrial cancer (20-60%), as well as several other cancers [Lynch and de la 5 Chapelle, 2003; Watson et al., 2008] . Lynch syndrome is caused by a germline mutation in 6 one of the DNA mismatch repair (MMR) genes MSH2, MLH1, MSH6 or PMS2 [Aaltonen et 7 al., 1998; Lynch and de la Chapelle, 2003; Hampel et al., 2005; Barnetson et al., 2006] (MIM 8 120436, 609309, 600678, 600259) . MSH2 and MLH1 account for the majority of the 9 identified mutations, whereas PMS2 mutations explain only a few percent of the confirmed 10 cases [Lynch and de la Chapelle, 2003; Barnetson et al., 2006] . 11
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Increasing evidence suggests that also epigenetic modifications may play a role in cancer 12 predisposition in Lynch syndrome. Several groups have reported the occurrence of mono-13 allelic methylation of the MLH1 gene promoter in peripheral blood cells of individuals that 14 meet the criteria for Lynch syndrome, but lack germline mutations in the MLH1 gene [Gazzoli 15 et al., 2002; Suter et al., 2004; Hitchins et al., 2007] . Occasionally, these so-called 16 epimutations were found to be transmitted over several generations, but the mechanism 17 underlying this phenomenon remains to be elucidated [Hitchins et al., 2007; Morak et al., 18 2008; Hesson et al., 2010] . Chan et al. [2006] for the first time reported an inherited germline 19 MSH2 epimutation in a family presenting with Lynch-associated tumors and a mosaic MSH2 20 hypermethylation pattern in normal tissues. Recently, we demonstrated that these families 21 carry 3' end deletions in the epithelial cell adhesion molecule gene EPCAM (MIM 185535), 22 previously known as TACSTD1, which is located upstream of the MSH2 gene. EPCAM is 23 highly expressed in epithelial tissues and carcinomas [Winter et al., 2003] , and these 24 deletions were found to result in transcriptional read-through into the MSH2 gene and 25 subsequent hypermethylation of its CpG island promoter in EPCAM-expressing tissues 26 [Ligtenberg et al., 2009] , thereby providing an explanation for the origin of the epimutation 27 and its mode of inheritance. The identification of several additional families with 3' EPCAM 28 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Klift et al., 2005; Kovacs et al., 2009; Niessen et al., 2009; 1 Nagasaka et al., 2010; Guarinos et al., 2010] has underscored the notion that these 2 abnormalities indeed represent a common cause of Lynch syndrome. 3
Here, we report the characterization of EPCAM deletions in 45 independent Lynch syndrome 4 families, including hypermethylation of the MSH2 gene promoter. The incidence of EPCAM 5 deletions appeared to vary between populations and was found to represent at least 1-3% of 6 the explained Lynch syndrome families. Detailed analysis of the EPCAM deletions uncovered 7 their range of variability as well as their Alu-repeat-mediated origin. 8
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John Wiley & Sons, Inc. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Germany (n=11), USA (n=4), UK (n=1), and Canada (n=1) were identified through targeted 5 genomic screens in cohorts of unexplained Lynch-like families, using variable inclusion 6 criteria, i.e., unexplained patients with MSH2-deficient and/or microsatellite-instable tumors 7 (Supporting Table S1 ). In addition, 18 EPCAM deletion families of various origins from earlier 8 studies were included in the breakpoint analyses (Supporting Table S1 ). All patient material 9 was obtained with informed consent. 10 11 Multiplex ligation-dependent probe amplification (MLPA) 12 EPCAM deletion screening was performed with MLPA using SALSA MLPA kits P072-B1 13 MSH6 or P008 MSH2/PMS2 (MRC-Holland, Amsterdam, The Netherlands). For fine-14 mapping of the identified deletions we used two custom-designed probe sets as previously 15 described [Ligtenberg et al., 2009] , in which two additional probes targeting the EPCAM 16 promoter region (probe O) and intron 4 of the EPCAM gene (probe P) were included ( Fig. 1) . 17
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Primers were designed using the MeltIngeny program according to guidelines provided by 18 MRC-Holland and are available upon request. 19 20
Long range PCR and breakpoint sequencing 21
Based on the MLPA results, long range PCR across the deletion was applied using a 22 TAKARA LA PCR kit (TaKaRa Bio Inc., Otsu, Shiga, Japan) or the Expand Long Range kit 23 (deletions 8, 9, 13, and 14; Roche Applied Sciences, Mannheim, Germany) . To identify the 24 exact breakpoints, the PCR products were directly sequenced at various positions in both 25 orientations. Primers used for these analyses are available upon request. 26
27

Methylation analysis 28
Page 7 of 30 John Wiley & Sons, Inc. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) analyses 1 were performed using SALSA MS-MLPA kit ME011 Mismatch Repair genes (MMR) (MRC-2 Holland) as previously described [Ligtenberg et al., 2009] , using 200 ng DNA isolated from 3 formalin fixed paraffin embedded material. Samples with known MGMT, MLH1 or MSH2 4 hypermethylation levels were used as positive controls. 5 6 Bioinformatic analysis of SINE density 7
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The density of short interspersed nuclear elements (SINEs), which include Alu repeats, in the 8 maximal deletion region was compared to the remainder of the genome by random sampling 9 of 10,000 genomic sequences of 25 kb in size. These sequences were obtained from hg18 10 (http://genome.ucsc.edu/) by random selection of autosomal chromosomes and subsequent 11 locations. Centromeres and gaps in the sequence alignment were excluded. These 25 kb 12 regions were annotated for the presence of all repeat masked elements, and the number of 13 SINE elements was calculated. Next, the 95% confidence interval for the presence of SINEs 14 within these 10,000 genomic regions was determined. In a search for novel germline EPCAM deletion cases we performed a multicenter screen of 4 unexplained Lynch-like families using multiplex ligation-dependent probe amplification 5 (MLPA) and/or deletion PCR, which yielded 27 novel EPCAM deletion families (Supporting 6   Table S1 ). Through the participation of all clinical genetic centers in The Netherlands, we 7 have now identified 17 unrelated Dutch families with EPCAM deletions, thus representing 8 2.8% of all explained Lynch syndrome families and 6.9% of all explained MSH2-deficient 9 families in this country, respectively (Table 1) . Additionally, 11 German EPCAM deletion 10 families were found in a systematic screen of 146 families with MSH2-deficient tumors in 11 which no MSH2 mutations were found (7.5%). Therefore, in Germany the frequency of 12 EPCAM deletion families in explained Lynch families is at least 1.1%, which is 2.3% of all 13 explained MSH2-deficient families. (Table 1) . 14 In addition to these 27 families, we included 18 EPCAM deletion families that were previously 15 reported by us and others ( Supporting Table S1 ). Together, these screens and searches 16 resulted in 45 independent families with EPCAM deletions originating from eight different 17 countries ( Supporting Table S2 ). Using long-range PCR we precisely localized and 18 sequenced the breakpoints in all EPCAM deletion families (Table 2 ). In total, 19 different 19 deletions were identified, varying in size from 2.6 to 23.8 kb. All deletions were located 20 upstream of the MSH2 gene promoter and encompassed at least the last two exons of the 21 EPCAM gene, leaving its 5' exons intact ( Fig. 1A ). Our breakpoint mapping data indicate that 22 a wide variety of EPCAM deletions does occur in these Lynch syndrome families. 23
24
EPCAM deletion carriers show MSH2 promoter hypermethylation 25
We previously showed for two different deletions (deletions 1 and 5, Table 2 ) that they result 26 in allele-specific hypermethylation of the MSH2 gene promoter in tissues expressing EPCAM 27 [Ligtenberg et al., 2009] . Here, we analyzed the methylation status of the MSH2 gene 28 promoter in tumor and/or normal colon mucosa tissues of at least one index patient from 1 each of 27 different families (encompassing 11 different deletions) using methylation-specific 2 multiplex ligation-dependent probe amplification (MS-MLPA, Table 2 , Supporting Table S2 ). 3 MSH2 promoter hypermethylation was detected in all tissues tested. One of the patients in 4 our cohort also developed a benign dermatofibroma, which was not MSH2-deficient and, in 5 contrast to the colorectal tumor, indeed was found to lack hypermethylation of the MSH2 6 gene promoter. Therefore, we conclude that hypermethylation of the MSH2 gene promoter in 7 tissues expressing EPCAM is a general phenomenon in the deletion carriers, thereby 8 explaining the concomitant cancer predisposition in these families. 9 10 EPCAM founder deletions 11
Several EPCAM deletions appeared to be widespread both within and between different 12 populations. The 4.9-kb EPCAM founder deletion, thus far observed in seven Dutch families 13 [Ligtenberg et al., 2009; Niessen et al., 2009] , was found to be present in nine out of ten 14 additional families from The Netherlands, but in none of the families from other geographic 15 origins, thus confirming its founder nature. Furthermore, this founder deletion appears to 16 represent a considerable fraction (~6.5%) of the explained MSH2-deficient Lynch syndrome 17 families in this population (Table 1 ). In addition, six EPCAM deletions were identified in more 18 than one family originating from Germany (deletions 2 and 14, n=2 and n=4, respectively), 19
Switzerland (deletion 3, n=2), and the USA (deletion 6, n=2) or from multiple origins 20 (deletions 5 and 10, n=3; Table 2 ). Although we cannot rule out with certainty that these 21 deletions have occurred independently, we anticipate that most of them will have an 22 ancestral origin. 23
24 Alu-mediated recombination as a mechanism of origin 25
It is well-established now that repetitive DNA sequences, such as Alu repeats, can act as 26 facilitators of chromosomal rearrangements [Stankiewicz et al., 2010] . Previous reports have 27 already suggested Alu repeat-mediated recombination as a likely mechanism for some of the 28 Page 10 of 30 John Wiley & Sons, Inc. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Klift et al., 2005; Kovacs et al., 2009; Ligtenberg et al., 2009] . 1 Indeed, all EPCAM deletion breakpoints characterized in this study were located within Alu 2 elements (Table 2 and Fig. 1 ). Together, the 19 different deletions involved 11 Alu repeats at 3 the distal intragenic breakpoints (within EPCAM), and 13 at the proximal breakpoints (in the 4 intergenic region between EPCAM and MSH2), of which several were involved in different 5 deletions ( Fig. 1B and 1C ). As expected, the two recombined Alu elements were always 6 directed in the same orientation, being either sense (deletions 5-11) or antisense (deletions 7 1-4 and 12-19). For 17/19 (89%) of the deletions, sequence alignment of the distal and 8
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proximal Alu repeats revealed the presence of stretches with microhomology at the 9 breakpoint, ranging from 6 to 32 bp in size (Table 2 and Supporting Fig. S1 ), which is in line 10 with Alu-Alu mediated non-allelic homologous recombination (NAHR). Interestingly, two 11 deletions of exactly the same size (deletions 7 and 8) appeared to originate from 12 recombination events at different positions within the same Alu repeat pair with high 13 sequence homology, further illustrating the homology-based mechanism driving these 14 genomic deletions (Fig. 2) . 15
The remaining two deletions (9 and 12) appear to have arisen by a mechanism different from 16 NAHR. Deletion 9, of which the breakpoints are near those of deletions 7 and 8 (Table 1) , 17 contains a 2-nt interstitial sequence (AG) and lacks microhomology at the breakpoint 18 junction. Similarly, the sequences surrounding the breakpoint junctions of deletion 12 do, 19 with only 3 bases, not contain sufficient homology in order to be explained by NAHR. In 20 these cases, classical non-homologous end-joining (NHEJ) or microhomology-mediated 21 break-induced repair (MMBIR) may serve as better explanations for the origin of the deletion 22 [McVety et al., 2005; Vissers et al., 2009] MSH2 locus in a genome-wide context. To this end, we randomly sampled 10,000 genomic 1 regions of 25 kb. This yielded a median Alu element density of 10 [95%CI: 0-39], which is 2 significantly lower than the density of 55 Alu elements that we observed within the 25-kb 3 EPCAM-MSH2 locus (Supporting Fig. S1 ). This local enrichment is also observed in other 4 regions with recurrent Alu-mediated rearrangements (e.g. the VHL locus in von Hippel-5 Lindau disease patients), but is absent in the locus encompassing the DNA mismatch repair 6 gene MLH1 (Supporting Fig. 2) . These observations may explain the wide variety of 7 deletions observed within the EPCAM-MSH2 locus. 8 Through detailed mapping and characterization of 3' EPCAM gene deletions in Lynch 2 syndrome families, we show that these deletions explain a considerable fraction (at least 1-3 3%) of all families with this syndrome, thus legitimating standard clinical testing. In total, we 4 have identified and characterized 19 different EPCAM deletions in 45 Lynch syndrome 5 families. These deletions turned out to be highly variable in size and location, but always 6 encompassed the last two exons of the EPCAM gene, including its polyadenylation signal. In 7 concordance with previous studies [Ligtenberg et al., 2009; Niessen et al., 2009; Nagasaka 8 et al., 2010] , all available tumor and normal colonic tissues showed hypermethylation of the 9 MSH2 gene promoter, thus confirming a direct correlation between these two aberrations. 10
Detailed localization of the deletion breakpoints at the sequence level revealed Alu-mediated 11 recombination as the major mechanism underlying the occurrence of EPCAM deletions. 12
The presence of a mono-allelic EPCAM deletion results in a highly efficient silencing of the 13 MSH2 gene in target tissues such as colonic mucosa. This observation is in full agreement 14 with the lifetime risk for colorectal cancer in these families, which appears to be similar to 15 those observed in families with other MSH2 alterations [Kempers et al, 2010] . This efficient 16
MSH2 inactivation may be associated with one or more of the following structural 17 characteristics of this locus: (i) the close vicinity of a neighboring gene (EPCAM) that is 18 oriented towards MSH2, and (ii) the high level of expression of EPCAM in targeted tissues 19 instilling MSH2 promoter methylation. Together with the relative high density of Alu repeat 20 elements in this genomic region, which increases the chance of Alu-mediated recombination, 21 these characteristics may explain the recurrent nature of variable EPCAM deletions in Lynch 22 syndrome families. 23
Upon analysis of the genomic region encompassing the Lynch-associated DNA mismatch 24 repair gene MLH1, we found that the above described characteristics do not apply to this 25 locus. Consequently, we postulate that in the previously reported families with germline 26 methylation of the MLH1 gene promoter, which in some families was found to be transmitted 27 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 [Hitchins et al., 2007; Morak et al., 2008; Hesson et al., 2010] , the 1 mechanism causing methylation is very likely to be different. 2
Previous reports have already pointed at correlations between Alu repeat densities and the 3 occurrence of genomic recombinations. For example, the VHL locus on 3p25.3 has a local 4
Alu element density which is comparable to that of the MSH2 locus on 2p21, and a similarly 5 high frequency and variety of Alu element-mediated deletions have been observed in von 6
Hippel-Lindau disease families [Franke et al., 2009; Nordstrom-O'Brien et al., 2010] . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 F o r P e e r R e v i e w of the deletions. Considering the high sequence homology between Alu repeats and the 1 microhomology observed at the breakpoint junctions, however, non-allelic homologous 2 recombination (NAHR) appears to be the most likely mechanism for most of the deletions. 3
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